Seizures associated with buspirone overdose: Case report and literature review

Clinical Neuropharmacology

Volumn 21, Issue 6, 1998, Pages 347-350

  Catalano, Glenn ^a,d   Catalano, Maria C ^b   Hanley, Paul F ^c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WRIGHT STATE UNIVERSITY   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Anxiolytics; Buspirone; Overdose; Seizures; Side Effects

Indexed keywords

ACTIVATED CARBON; BUSPIRONE; LORAZEPAM; NALOXONE; PHENYTOIN; THIAMINE;

ADULT; ARTICLE; CASE REPORT; DRUG OVERDOSE; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEIZURE; STOMACH LAVAGE; SUICIDE ATTEMPT;

ADULT; ANTI-ANXIETY AGENTS; BUSPIRONE; FEMALE; HUMANS; OVERDOSE; SEIZURES;

EID: 0031755742     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Baldessarini RJ. Drugs and the Treatment of Psychiatric Disorders: Psychosis and Anxiety. In: Hardman JG, Goodman Gilman A, Limbird LE, Molinoff PB, Ruddon RW, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th Edition. New York: McGraw-Hill, 1996:399-430.
2. Taylor DP, Riblet LA, Stanton HC, Eison AS, Eison, MS, Temple DL. Dopamine and Antianxiety Activity. Pharmacol Biochem Behav 1982;17 (suppl. 1):25-35.
3. Goa KL, Ward A. Buspirone A Preliminary Review of its Pharmacological Properties and Therapeutic Efficacy as an Anxiolytic. Drugs 1986;32:114-29.
4. Eison As, Temple DL. Buspirone: Review of its Pharmacology and Current Perspectives on its Mechanism of Action. Am J Med 1986;80 (suppl. 3b):1-9.
5. DeMaio D. Clinical Notes on Buspirone. Pharmacol Biochem Behav 1988;29:821-2.
6. Riblet LA, Taylor DP, Eison MJ, Stanton HC. Pharmacology and Neurochemistry of Buspirone. J Clin Psychiatry 1982;43 (sec 2):11-6.
7. Riblet LA, Eison AS, Eison MS, Newton RE, Taylor DP, Temple DL. Buspirone: An Anxioselective Alternative for the Management of Anxiety Disorders. Prog Neuropsychopharmacol Biol Psychiatry 1983;7:663-8.
8. Tiller JWG. The New and Newer Antianxiety Agents. Med J Aust 1989;151:697-701.
9. Taylor DP, Moon SL. Buspirone and Related Compounds as Alternative Anxiolytics. Neuropeptides 1991;19(suppl.):15-9.
10. Schnabel T. Evaluation of the Safety and Side Effects of Antianxiety Agents. Am J Med 1987;82 (suppl. 5a):7-13.
11. Lader M. Long-Term Anxiolytic Therapy. The Issue of Drug Withdrawal. J Clin Psychiatry 1987;48 (suppl.):12-6.
12. Newton RE, Marunycz CE, Alderdice MT, Napoliello MJ. Review of the Side-Effect Profile of Buspirone. Am J Med 1986;80 (suppl. 3b):17-21.
13. LeWitt PA, Walters A, Hening W, McHale D. Persistent Movement Disorders Induced by Buspirone. Mov Disord 1993;8:331-4.
14. Soni P, Weintraub AL. Buspirone-Associated Mental Status Changes. J Am Acad Child Adolesc Psychiatry 1992;31:1098-9.
15. Ritchie EC, Bridenbaugh RH, Jabbari B. Acute Generalized Myoclonus Following Buspirone Administration. J Clin Psychiatry 1988; 49:242-3.
16. Langlois RP, Paquette D. Sustained Bradycardia During Fluvoxamine and Buspirone Intoxication. Can J Psychiatry 1994;39: 126-7.
17. Tiller JWG, Burrows GD, O'Sullivan BT. Buspirone Overdose. Med J Aust 1989;150:54-5.
18. Sathananthan GL, Sanghvi I, Phillips N, Gershon S. MJ 9022: Correlation Between Neuroleptic Potential and Stereotypy. Curr Therap Res Clin Exp 1975;18:701-5.
19. Rosse RB, Deutsch LH, Deutsch SI. Medical Assessment and Laboratory Testing in Psychiatry. In: Kaplan HI, Sadock BJ, eds. Comprehensive Textbook of Psychiatry VI. Baltimore: Williams & Wilkins, 1995:601-19.
20. Uhde TW, Tancer ME. Buspirone. In: Kaplan HI, Sadock BJ, eds. Comprehensive Textbook of Psychiatry VI. Baltimore: Williams & Wilkins, 1995:1957-61.
21. Anderson MC, Chung E, Van Woert MH. Strychnine Seizure Potentiation by Azapirodecanedione Anxiolytics in Rats. Eur J Pharmacol 1988;155:279-83.
22. Peroutka SJ, Gonzales DA, Shapiro M. Modulation of Postdecapitation Convulsions in Rats by Alpha Adrenergic and 5-Hydroxytryptamine 1A Agents. Exp Neurol 1987;96:344-51.
23. Kadota T, Kawano S, Chikazawa H, et al. Acute Toxicity Study of Buspirone Hydrochloride in Mice, Rats and Dogs. J Toxicol Sci 1990;15(suppl. 1):1-14.